Skip to main content

Table 1 Information about human postmortem tissue samples

From: Enhanced phosphorylation of T153 in soluble tau is a defining biochemical feature of the A152T tau risk variant

A152T carriers

Noncarriers

Code

Braak

Age; Gender

Code

Braak

Age; Gender

ADv1

5

81; F

AD1

6

80; F

ADv2

6

96; M

AD2

5.5

91; M

ADv3

6

86; M

AD3

5

84; M

ADv4

4.5

80; F

AD4

5

80; F

ADv5

6

91; F

AD5

6

83; F

ADv6

5

67; M

AD6

6

61; M

PSPv1

2

67; M

PSP1

1

69; M

PSPv2

3

74; F

PSP2

3

74; M

PSPv3

1

81; F

PSP3

1

80; F

PSPv4

3

77; M

PSP4

2.5

76; M

PSPv5

3

77; F

PSP5

3.5

81; F

LBDv1

3

75; M

LBD1

3.5

72; M

LBDv2

2.5

72; M

LBD2

0

72; M

CBDv1

3

68; F

CBD1

3

67; F

fMNDv1 (C9+)

0

62; F

fMND1 (C9+)

2

55; F

  1. AD Alzheimer’s disease, PSP Progressive supranuclear palsy, LBD Lewy body dementia, CBD Corticobasal degeneration, fMND (C9+) Frontotemporal lobar degeneration with motor neuron disease associated with C9ORF72 mutation
Back to article page